Page last updated: 2024-11-05

trifluoperazine and Parkinson Disease, Secondary

trifluoperazine has been researched along with Parkinson Disease, Secondary in 20 studies

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research Excerpts

ExcerptRelevanceReference
"Dysphagia is a potentially life-threatening complication of drug-induced parkinsonism."1.29Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. ( Bashford, G; Bradd, P, 1996)

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-199018 (90.00)18.7374
1990's1 (5.00)18.2507
2000's0 (0.00)29.6817
2010's1 (5.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sadananda, SK1
Holla, B1
Viswanath, B1
Narasimha, A1
Sebastian, A1
Math, SB1
Chandrashekar, CR1
Sheppard, C1
Merlis, S1
Keshavan, MS1
Narashimha Rao, IV1
Narayanan, HS1
Bashford, G1
Bradd, P1
Sahoo, RN1
Mitra, GC1
Mohanty, PC1
Stokes, HB1
Martin, IC1
Crowley, TJ3
Hoehn, MM3
Rutledge, CO3
Stallings, MA2
Heaton, RK1
Sundell, S2
Stilson, D1
Srikant, G1
Kantharaj, L1
Rao, PR1
Van Woert, MH2
Sethy, VH1
Ambani, LM2
Bordeleau, JM1
Tétreault, L1
Morrison, AB1
Webster, RA1
Bowers, MB1
Demars, JP1
Zolotnitskii, RI1
Kutsenok, BM1
Gastev, MD1
Ridges, AP1
Harper, P1
Fischer, R1
Knopp, W1
Griffin, F1
Ekdawi, MY1
Fowke, R1

Trials

2 trials available for trifluoperazine and Parkinson Disease, Secondary

ArticleYear
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
    Acta psychiatrica Scandinavica, 1975, Volume: 51, Issue:2

    Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat

1975
Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy.
    The Journal of nervous and mental disease, 1966, Volume: 143, Issue:1

    Topics: Aged; Chlorpromazine; Clinical Trials as Topic; Electric Stimulation Therapy; Female; Haloperidol; H

1966

Other Studies

18 other studies available for trifluoperazine and Parkinson Disease, Secondary

ArticleYear
Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly.
    The journal of ECT, 2013, Volume: 29, Issue:1

    Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Electroconvulsive Therapy; Humans; Male; Middle Aged

2013
Drug-induced extrapyramidal symptoms: their incidence and treatment.
    The American journal of psychiatry, 1967, Volume: 123, Issue:7

    Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp

1967
Rate of blinking may predict neuroleptic-induced parkinsonism.
    The British journal of psychiatry : the journal of mental science, 1983, Volume: 142

    Topics: Blinking; Humans; Parkinson Disease, Secondary; Trifluoperazine

1983
Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.
    Journal of geriatric psychiatry and neurology, 1996, Volume: 9, Issue:3

    Topics: Aged; Deglutition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administrat

1996
Irreversible drug induced parkinsonism (two case reports).
    The Journal of the Association of Physicians of India, 1975, Volume: 23, Issue:8

    Topics: Adult; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Phenothiazines; Prochlorperazine; Tr

1975
Trifluoroperazine for the symptomatic treatment of chorea.
    Diseases of the nervous system, 1975, Volume: 36, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Cerebrovascular Disorders; Child; Chorea; Drug Evaluation; Female;

1975
Dopamine excretion and vulnerability to drug-induced Parkinsonism. Schizophrenic patients.
    Archives of general psychiatry, 1978, Volume: 35, Issue:1

    Topics: Adult; Dopamine; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease, Secondary

1978
The Parkinsonian syndrome and its dopamine correlates.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic A

1977
Low urinary dopamine and prediction of phenothiazine-induced Parkinsonism: a preliminary report.
    The American journal of psychiatry, 1976, Volume: 133, Issue:6

    Topics: Adult; Dopamine; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease, Secondary;

1976
Two cases of parkinsonism developing after industrial exposure to trifluperazine.
    The Journal of the Association of Physicians of India, 1986, Volume: 34, Issue:6

    Topics: Adult; Humans; Male; Occupational Diseases; Parkinson Disease, Secondary; Trifluoperazine

1986
Effect of phenothiazines on central cholinergic activity.
    Advances in biochemical psychopharmacology, 1974, Volume: 9, Issue:0

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Brain Chemistry; Chlorp

1974
[Study of extrapyramidal manifestations induced by neuroleptics].
    Revue canadienne de biologie, 1972, Volume: 31

    Topics: Antiparkinson Agents; Chlorpromazine; Drug Synergism; Extrapyramidal Tracts; Fluphenazine; Haloperid

1972
Drug-induced experimental Parkinsonism.
    Neuropharmacology, 1973, Volume: 12, Issue:8

    Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr

1973
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
    Archives of neurology, 1973, Volume: 29, Issue:6

    Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H

1973
[On the results of treatment and complications during the use of haloperidol in patients with long-term schizophrenia].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1969, Volume: 69, Issue:5

    Topics: Adult; Blood Pressure; Cardiovascular Diseases; Catatonia; Chlorpromazine; Cognition Disorders; Hall

1969
Pink spot--is it a drug artefact?
    Psychiatria clinica, 1970, Volume: 3, Issue:2

    Topics: Amitriptyline; Amobarbital; Chlorpromazine; Chromatography; Haloperidol; Humans; Mental Disorders; P

1970
Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms.
    Arzneimittel-Forschung, 1965, Volume: 15, Issue:12

    Topics: Extrapyramidal Tracts; Female; Humans; Movement Disorders; Parkinson Disease, Secondary; Phenothiazi

1965
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
    The British journal of psychiatry : the journal of mental science, 1966, Volume: 112, Issue:487

    Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic

1966